Showing results (141-150 of 164) with videos related to
Sort By:
Pageof 17
Breast Cancer Research and Treatment|October 17, 1998
Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: results from a multicenter prospective randomized trialD Amadori, G L Frassineti, A De Matteis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1990
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer GroupR C Coombes, P S Schein, C E Chilvers, et al.Recenti Progressi in Medicina|November 7, 2001
[Prevalence of anemia in oncologic patients treated with chemotherapy. Italian survey at the national level]G Bernardo, M Aglietta, D Amadori, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO)P F Conte, E Baldini, G Gardin, et al.British Journal of Cancer|October 10, 2002
Role of biological markers in the clinical outcome of colon cancerO Nanni, A Volpi, G L Frassineti, et al.British Journal of Cancer|February 14, 1998
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II studyC Aschele, A Guglielmi, G L Frassineti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2006
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control studyG Gorini, E Stagnaro, V Fontana, et al.British Journal of Cancer|April 22, 2015
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abirateroneS Salvi, V Casadio, V Conteduca, et al.European Journal of Cancer (Oxford, England : 1990)|June 14, 2011
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerD Amadori, C Milandri, G Comella, et al.Cell Proliferation|May 15, 2009
Isolation of stem/progenitor cells from normal lung tissue of adult humansA Tesei, W Zoli, C Arienti, et al.Pageof 17